120 related articles for article (PubMed ID: 35383609)
1. Comment to: Inequalities in adherence to cervical cancer screening in Portugal.
Mihály-Vajda R; Csákvári T; Pónusz-Kovács D; Varga V; Kajos FL; Boncz I
Eur J Cancer Prev; 2022 May; 31(3):310-312. PubMed ID: 35383609
[No Abstract] [Full Text] [Related]
2. Inequalities in adherence to cervical cancer screening in Portugal.
Nunes MF; Leite AH; Dias SF
Eur J Cancer Prev; 2021 Mar; 30(2):171-177. PubMed ID: 32732693
[TBL] [Abstract][Full Text] [Related]
3. Stepwise strategy to improve cervical cancer screening adherence (SCAN-Cervical Cancer) - Automated text messages, phone calls and reminders: Population based randomized controlled trial.
Firmino-Machado J; Varela S; Mendes R; Moreira A; Lunet N;
Prev Med; 2018 Sep; 114():123-133. PubMed ID: 29894717
[TBL] [Abstract][Full Text] [Related]
4. [Inequalities in cervical screening practices].
Döbrőssy L; Kovács A; Budai A
Orv Hetil; 2015 Jun; 156(24):955-63. PubMed ID: 26051131
[TBL] [Abstract][Full Text] [Related]
5. Disparities in cervical cancer screening in the United States.
Lepe M
Cancer Cytopathol; 2024 Apr; 132(4):205-208. PubMed ID: 37519242
[No Abstract] [Full Text] [Related]
6. A 3-step intervention to improve adherence to cervical cancer screening: The SCAN randomized controlled trial.
Firmino-Machado J; Varela S; Mendes R; Moreira A; Lunet N;
Prev Med; 2019 Jun; 123():250-261. PubMed ID: 30936001
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
Alves C; Alves L; Lunet N
Eur J Cancer Prev; 2009 Nov; 18(6):482-8. PubMed ID: 19734793
[TBL] [Abstract][Full Text] [Related]
8. Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey.
Oliveira M; Peleteiro B; Lunet N
Eur J Public Health; 2014 Apr; 24(2):253-8. PubMed ID: 23788013
[TBL] [Abstract][Full Text] [Related]
9. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
[TBL] [Abstract][Full Text] [Related]
10. Developing a hand-held Pap test card to improve cervical cancer screening.
Prendergast MB; Hunter LP
Nurs Womens Health; 2014; 18(3):212-9. PubMed ID: 24939198
[TBL] [Abstract][Full Text] [Related]
11. Saving the World's Women from Cervical Cancer.
Tsu V; Jerónimo J
N Engl J Med; 2016 Jun; 374(26):2509-11. PubMed ID: 27355529
[No Abstract] [Full Text] [Related]
12. Socioeconomic Inequalities in Cervical and Breast Cancer Screening among Women in Korea, 2005-2015.
Choi E; Lee YY; Suh M; Lee EY; Mai TTX; Ki M; Oh JK; Cho H; Park B; Jun JK; Kim Y; Choi KS
Yonsei Med J; 2018 Nov; 59(9):1026-1033. PubMed ID: 30328316
[TBL] [Abstract][Full Text] [Related]
13. [Self-sampling and reminder letters increase participation in the Finnish cervical cancer screening programme].
Virtanen A; Nieminen P; Malila N; Luostarinen T; Anttila A
Duodecim; 2013; 129(16):1709-17. PubMed ID: 24069641
[TBL] [Abstract][Full Text] [Related]
14. [In Italy, more and more women undertake tests for early diagnosis of cervical cancer within organized screening programmes].
Carrozzi G; Sampaolo L; Bolognesi L; Bertozzi N; Ferrante G; Minardi V; Masocco M;
Epidemiol Prev; 2016; 40(6):476. PubMed ID: 27919156
[No Abstract] [Full Text] [Related]
15. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
Constantinou P; Dray-Spira R; Menvielle G
BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
[TBL] [Abstract][Full Text] [Related]
16. Cervical cytology use in Portugal: Results from the National Health Survey 2014.
Rukhadze L; Lunet N; Peleteiro B
J Obstet Gynaecol Res; 2019 Jul; 45(7):1286-1295. PubMed ID: 31034140
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 on cervical cancer screening.
Mungmunpuntipamtip R; Wiwanitkit V
Eur J Cancer Prev; 2022 Jul; 31(4):400. PubMed ID: 34456261
[No Abstract] [Full Text] [Related]
18. Time trends in cervical cancer screening rates in the OECD countries.
Machii R; Saito H
Jpn J Clin Oncol; 2011 May; 41(5):731-2. PubMed ID: 21536695
[No Abstract] [Full Text] [Related]
19. Cervical cancer screening: a prospective cohort study of the effects of historical patient compliance and a population-based informatics prompted reminder on screening rates.
MacLaughlin KL; Swanson KM; Naessens JM; Angstman KB; Chaudhry R
J Eval Clin Pract; 2014 Apr; 20(2):136-43. PubMed ID: 24237657
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening coverage in a high-incidence region.
Navarro C; Fonseca AJ; Sibajev A; Souza CI; Araújo DS; Teles DA; Carvalho SG; Cavalcante KW; Rabelo WL
Rev Saude Publica; 2015; 49():17. PubMed ID: 25741655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
